Revolutionary Biophotonic E-Textile Wearable for Health

About Niraxx

Niraxx is a MedTech company creating a new category of wearable light therapy devices for brain health and overall wellness. We’ve taken the data from years of research and science on the benefits of Low Level Light Therapy and translated it into effective self-care solutions for people who are looking to gain an edge in their everyday wellness and proactively work towards a longer, healthier life.

Our Mission

Some of the largest health problems facing the world today, such as mental health and addiction, lack effective care solutions.

Our mission is to develop biophotonic E-Textile therapeutics products that are affordable, portable and accessible. Our goal is to address public health issues by delivering personalized care and health management solutions to the greatest number of people. We want no one left behind.

Our Team

Joshua Chen

With 25 years of entrepreneurial experience Joshua is the founder and chairman of two companies.
In 2001, Joshua founded Nature Bright Co.: a company that manufactures and distributes light therapy products.
Joshua has been nominated “Innovator of the Year” by the Orange County Business Journal for two consecutive years.

Dr. Paolo Cassano

Dr. Cassano is an Assistant Professor in Psychiatry at Harvard Medical School, and Director of Photobiomodulation at the Massachusetts General Hospital Center for Anxiety and Traumatic Stress Disorders and Depression and Clinical Research Program. Dr. Cassano has over 10 years of experience in treatment of depressive disorders with low level laser therapy and brain bioenergetics.

Meg Burich

Meg is a leader in the field of wearable technology for fitness and health. She was instrumental in commercializing the first wearable sensor garments while at Textronics, a start up later acquired by adidas where she spent 10 years as Sr. Marketing Director, Commercial Development for digital products.
Meg holds five patents in the area of connected wearables for sports and fitness.

Scientific Advisory Board

Dr. Alvaro Pascual-Leone

Professor of Neurology at Harvard. His research aims at understanding the mechanisms that control brain plasticity across the life to prevent age-related cognitive decline, reduce the risk for dementia, and minimize the impact of neurodevelopmental disorders

Dr. Maurizio Fava

Founder of Massachusetts General Hospital’s Depression Clinical and Research Program (DCRP) one of the most highly
regarded depression programs in the country.
Dr. Fava is a world leader in the field of depression.

Dr. Michael R. Hamblin

Principal Investigator at the Wellman Center for Photomedicine at Massachusetts General Hospital. Dr Hamblin is world-renowned in the field of Photomedicine.

Dr. Justin Baker

Scientific Director, Institute for Technology in Psychiatry. Director of functional neuroimaging and bioinformatics for the Schizophrenia and
Bipolar Disorder Research Program at McLean Hospital. Assistant Professor Psychiatry, Harvard.

Dr. Mari Franceschini

A pioneer in the field of near-infrared spectroscopy (fNIRs). Focused on the development of non-invasive optical techniques and application in the neurosciences, neurology, and brain health.

Dr. Andre Brunoni

Director of two clinical and research centers at
the University of São Paulo. Dr. Brunoni specializes in Internal Medicine and Psychiatry.
His research involves the use of non-invasive brain stimulation techniques.

Research Affiliation